Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
SingHealth Regional Health System PULSES Centre, Singapore Health Services, Outram Rd, Singapore, 169608, Singapore.
BMC Med Res Methodol. 2021 Mar 11;21(1):49. doi: 10.1186/s12874-021-01209-w.
Population segmentation permits the division of a heterogeneous population into relatively homogenous subgroups. This scoping review aims to summarize the clinical applications of data driven and expert driven population segmentation among Type 2 diabetes mellitus (T2DM) patients.
The literature search was conducted in Medline®, Embase®, Scopus® and PsycInfo®. Articles which utilized expert-based or data-driven population segmentation methodologies for evaluation of outcomes among T2DM patients were included. Population segmentation variables were grouped into five domains (socio-demographic, diabetes related, non-diabetes medical related, psychiatric / psychological and health system related variables). A framework for PopulAtion Segmentation Study design for T2DM patients (PASS-T2DM) was proposed.
Of 155,124 articles screened, 148 articles were included. Expert driven population segmentation approach was most commonly used, of which judgemental splitting was the main strategy employed (n = 111, 75.0%). Cluster based analyses (n = 37, 25.0%) was the main data driven population segmentation strategies utilized. Socio-demographic (n = 66, 44.6%), diabetes related (n = 54, 36.5%) and non-diabetes medical related (n = 18, 12.2%) were the most used domains. Specifically, patients' race, age, Hba1c related parameters and depression / anxiety related variables were most frequently used. Health grouping/profiling (n = 71, 48%), assessment of diabetes related complications (n = 57, 38.5%) and non-diabetes metabolic derangements (n = 42, 28.4%) were the most frequent population segmentation objectives of the studies.
Population segmentation has a wide range of clinical applications for evaluating clinical outcomes among T2DM patients. More studies are required to identify the optimal set of population segmentation framework for T2DM patients.
人群细分允许将异质人群划分为相对同质的亚组。本范围综述旨在总结数据驱动和专家驱动的 2 型糖尿病(T2DM)患者人群细分的临床应用。
文献检索在 Medline ® 、Embase ® 、Scopus ® 和 PsycInfo ® 中进行。纳入了使用基于专家或基于数据的人群细分方法评估 T2DM 患者结局的文章。人群细分变量分为五个领域(社会人口统计学、糖尿病相关、非糖尿病医学相关、精神/心理和卫生系统相关变量)。提出了用于 T2DM 患者的人群细分研究设计框架(PASS-T2DM)。
在筛选出的 155,124 篇文章中,有 148 篇被纳入。最常用的是专家驱动的人群细分方法,其中主要采用的策略是判断分割(n=111,75.0%)。基于聚类的分析(n=37,25.0%)是最常用的数据驱动人群细分策略。社会人口统计学(n=66,44.6%)、糖尿病相关(n=54,36.5%)和非糖尿病医学相关(n=18,12.2%)是使用最多的领域。具体来说,患者的种族、年龄、Hba1c 相关参数和抑郁/焦虑相关变量最常被使用。健康分组/分析(n=71,48%)、评估糖尿病相关并发症(n=57,38.5%)和非糖尿病代谢紊乱(n=42,28.4%)是研究中最常见的人群细分目标。
人群细分在评估 T2DM 患者的临床结局方面有广泛的临床应用。需要更多的研究来确定 T2DM 患者最佳的人群细分框架。